Marie-Laure Risse Selected Research

Docetaxel (Taxotere)

11/2006

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marie-Laure Risse Research Topics

Disease

9	Multiple Myeloma 10/2022 - 05/2018
2	Neoplasms (Cancer) 01/2021 - 10/2003
1	Residual Neoplasm 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013
1	Stomach Neoplasms (Stomach Cancer) 11/2006

Drug/Important Bio-Agent (IBA)

9	isatuximabIBA 10/2022 - 05/2018
8	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 05/2018
7	carfilzomibIBA 10/2022 - 01/2020
3	Monoclonal AntibodiesIBA 06/2022 - 01/2021
2	pomalidomideIBA 01/2021 - 05/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2013 - 11/2006
1	antineoplaston A10 (A 10)IBA 01/2022
1	Gemcitabine FDA Link 01/2013
1	larotaxelIBA 01/2013
1	Pharmaceutical PreparationsIBA 11/2006
1	Docetaxel (Taxotere)FDA Link 11/2006
1	thiamine triphosphorate (TTP)IBA 11/2006
1	Fluorouracil (Carac)FDA LinkGeneric 11/2006
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2003

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2006
1	Intravenous Infusions 10/2003